| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nano Dimension Ltd.
13D/A
Amendment 3
NNDM · 63008G203
|
3.3% |
7/22/2026
Event 7/20/2026
|
|||
|
Nano Dimension Ltd.
13D/A
Amendment 2
NNDM · 63008G203
|
7.2% |
6/17/2026
Event 6/15/2026
|
|||
|
Lifeward Ltd.
13D
LFWD · M8216Q309
|
49.9% |
5/14/2026
Event 3/25/2026
|
|||
|
Nano Dimension Ltd.
13D/A
Amendment 1
NNDM · 63008G203
|
5.2% |
2/19/2026
Event 2/17/2026
|
|||
|
Scilex Holding Co
13G/A
Amendment 4
SCLX · 80880W205
|
4.9% |
2/13/2026
Event 12/31/2025
|
|||
|
Nano Dimension Ltd.
13D
NNDM · 63008G203
|
5.0% |
1/29/2026
Event 1/29/2026
|
|||
| Oramed Pharmaceuticals Inc. | 5.0% | ||||
| Nadav Kidron | 5.0% | ||||
|
Scilex Holding Co
13G/A
Amendment 3
SCLX · 80880W205
|
9.9% |
11/14/2025
Event 9/30/2025
|
|||
|
Scilex Holding Co
13G/A
Amendment 2
SCLX · 80880W205
|
9.9% |
8/14/2025
Event 6/30/2025
|
|||
|
Scilex Holding Company
13G/A
Amendment 1
SCLX · 80880W106
|
9.9% |
5/8/2025
Event 3/31/2025
|
|||
|
Alpha Tau Medical Ltd.
13D
DRTS · M0740A108
|
20.0% |
5/1/2025
Event 4/24/2025
|
|||
| Oramed Pharmaceuticals Inc. | 20.0% | ||||
| Oramed Ltd. | 20.0% | ||||
|
Scilex Holding Company
13G
SCLX · 80880W106
|
6.2% |
1/17/2025
Event 1/13/2025
|
|||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.